Genoa acquires Northeast Pharmaceuticals
Genoa, a QoL Healthcare Company, has acquired long-term care pharmacy provider Northeast Pharmaceuticals Inc. Financial terms of the deal, announced this week, weren’t disclosed. Montgomery, Ala.
Pharmacy
CVS Health to buy Target’s pharmacy business
WOONSOCKET, R.I. – CVS Health plans to acquire Target Corp.’s U.S. pharmacy and retail health clinics businesses for about $1.9 billion.
Glenmark ships Dovonex generic
Glenmark Pharmaceuticals Inc. USA has been granted final approval by the Food and Drug Administration for calcipotriene cream, a psoriasis medication. Glenmark said Thursday that it plans to begin shipping of its calcipotriene cream product, a generic version of Dovonex Cream 0.
Ads highlight pharmacists as health providers
This month, the Patient Access to Pharmacists’ Care Coalition (PAPCC) released newspaper ads and radio spots urging Congress to pass the Pharmacy and Medically Underserved Areas Enhancement Act (S. 314/H.R. 592).
Walgreens ramps up telehealth services
Walgreens plans to expand telehealth services access via its mobile app and website to 25 states by the end of this year.
HDMA honors McKesson’s Julian with Nexus Award
McKesson Corp. executive Paul Julian has received the 2015 Nexus Award for Lifetime Achievement from the Healthcare Distribution Management Association’s Center for Healthcare Supply Chain Research and Genentech Inc.
Cardinal Health to buy Harvard Drug Group
Cardinal Health Inc. plans to acquire pharmaceutical distributor The Harvard Drug Group (THDG) from private equity firm Court Square Capital Partners for $1.115 billion.
Fruth Pharmacy offers talking Rx label for visually impaired
This month, Fruth Pharmacy plans to help demonstrate a new talking prescription label for the visually impaired. The regional drug chain has rolled out the AccessaMed prescription label to all of its 26 stores in West Virginia and Ohio.
Mylan, Teva roll out generic versions of Intuniv
Mylan N.V. and Teva Pharmaceutical Industries Ltd. have released guanfacine extended-release tablets, a nonstimulant medication for attention deficit hyperactivity disorder (ADHD), in the United States.
Lannett wraps up Silarx acquisition
Lannett Co. has completed its acquisition of Silarx Pharmaceuticals Inc, , a manufacturer and marketer of liquid generic drug products. The deal also includes a related real estate entity, Lannett said Tuesday.
Teva launches pair of new generics
Teva Pharmaceutical Industries Ltd. has released generic versions of Actavis’ Actonel tablets, an osteoporosis medication, and of Amneal’s Lomedia 24 Fe, a women’s contraceptive, in the United States.
AmerisourceBergen plans three new DCs
AmerisourceBergen Corp. is set to begin construction on three new distribution centers, to be located in Olive Branch, Miss.; Shakopee, Minn.; and Newburgh, N.Y. AmerisourceBergen said Monday that building for the new facilities is slated to start this summer and take 18 to 24 months to complete.
RxMedic expands automated dispensing lineup with RM200
RxMedic Systems has introduced a new pharmacy robot, the RM200, which is engineered to use exclusive TriMaxx triangular vials. The pharmacy automation provider, a subsidiary of JM Smith Corp.
Option Care emerges as an independent entity
Walgreens Infusion Services is now Option Care, an independent company and brand, though Walgreens has retained “significant” minority ownership. Madison Dearborn Partners (MDP), a private equity firm based in Chicago, now owns the lion’s share of the new infusion services provider.
State biosimilars legislation hailed by GPhA
The Generic Pharmaceutical Association (GPhA) and its recently formed Biosimilars Council have praised the enactment of new legislation in five states to allow automatic substitution for Food and Drug Administration-approved interchangeable biologic products.
Lilly marks a first with Humalog U-200 KwikPen
Eli Lilly and Co. has been cleared by the Food and Drug Administration to market the Humalog 200 units/ml KwikPen, which the company called the first concentrated mealtime insulin analog approved in the United States.